Vijaya Diagnostic Centre logo

Vijaya Diagnostic Centre CEO, MD, chairman, board of directors and AGM

NSE: VIJAYABSE: 543350Healthcare ServicesSmall Cap

Last close ₹1,389.40down ₹1.40 (0.10%)BSE ₹1,388.05

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,390.80.

52-week range of traded prices to 23 Oct 2026
₹848.00Low, 30 Mar 2026₹1,593.60High, 23 Sep 2026
Market cap
₹14,311 Cr523rd largest listed
P/E
76.3
P/B
15.0
Dividend yield
0.14%
ROE
21.4%
ROCE
27.8%
Debt to equity
0.00
Volume, NSE
1,59,08557.1% delivered

Vijaya Diagnostic Centre board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonSura Surendranath ReddyRelated to the promoter
  • Managing director and CEOSura Suprita Reddy

8 directors4 independent3 executive1 non-executive

  • Sura Surendranath Reddy · ChairpersonExecutive · joined Jun 2002 · reappointed Oct 2024 · 1 listed board
  • Sunil Chandra KondapallyExecutive · joined Jun 2002 · reappointed Oct 2024 · 1 listed board · 1 committee seat
  • Sura Geeta ReddyNon-executive · joined Nov 2019 · 1 listed board
  • Sura Suprita Reddy · Managing director and CEOExecutive · joined Jul 2023 · reappointed Jul 2023 · 1 listed board · 2 committee seats
  • Ravi ShankararamiahIndependent · joined Feb 2026 · reappointed Feb 2026 · 7 months as independent · 1 listed board · 1 as independent
  • Sasikala Paruchuri KolaIndependent · joined Feb 2026 · reappointed Feb 2026 · 7 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Satyanaryana Murthy ChavaliIndependent · joined May 2021 · reappointed May 2026 · 64 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Dipinder Singh SekhonIndependent · joined May 2026 · reappointed May 2026 · 4 months as independent · 1 listed board · 1 as independent · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

3 directors who left
  • Manjula Anagani, left 21 Aug 2026: Tenure Completion
  • Duvvur Nageshwar Reddy, left 25 May 2026: Tenure Completion
  • Shekhar Prasad Singh, left 25 May 2026: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 11 Sep 20267 of 8 present4 independent · 35 days in between
    • 6 Aug 20267 of 9 present4 independent · 27 days in between
    • 9 Jul 20267 of 9 present3 independent · 62 days in between
    • 7 May 202610 of 10 present6 independent

  • Audit Committee

    Chair Satyanaryana Murthy Chavali

    Dipinder Singh Sekhon, Sura Suprita Reddy

    • 11 Sep 20263 of 3 present2 independent · 35 days in between
    • 6 Aug 20263 of 3 present2 independent · 90 days in between
    • 7 May 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Ravi Shankararamiah

    Sasikala Paruchuri Kola, Sura Geeta Reddy

    • 6 Aug 20263 of 3 present2 independent · 27 days in between
    • 9 Jul 20262 of 3 present1 independent · 62 days in between
    • 7 May 20263 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair Sasikala Paruchuri Kola

    Sunil Chandra Kondapally, Sura Suprita Reddy

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Sunil Chandra Kondapally

    Sura Suprita Reddy, Ravi Shankararamiah

    • 11 Sep 20263 of 3 present1 independent · 126 days in between

  • Corporate Social Responsibility Committee

    Chair Dipinder Singh Sekhon

    Sura Geeta Reddy, Satyanaryana Murthy Chavali

    • 7 May 20264 of 4 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • B S R and CoPeer-review certificate valid to Apr 2029

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Vijaya Diagnostic Centre AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Vijaya Diagnostic Centre dividend history

Annual general meeting, 24 Sep 2026

71,324 shareholders on the register on 16 Sep 2026; present: 4 promoters and 64 others; votes counted by BALARAMAKRISHNA DESINA / BALARAMAKRISHNA & ASSOCIATES.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, and the Reports of the Board of Directors and Statutory Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 93.11% · promoters 99.94% · institutions 94.12% · other public 2.41%

  2. To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the Report of Statutory Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 93.11% · promoters 99.94% · institutions 94.12% · other public 2.41%

  3. To declare final dividend of ₹2 (i.e., 200%) per equity share of face value of ₹1/- each for the financial year ended March 31, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 93.13% · promoters 99.94% · institutions 94.15% · other public 2.41%

  4. To appoint a director in place of Mrs. Sura Geeta Reddy (DIN: 01073233), who retires by rotation in terms of section 152(6) of the Companies Act, 2013, and being eligible, offers herself for re-appointment.MoreLess
    Ordinary
    92.13% for7.87% against

    Against: promoters 0.00% · institutions 18.05% · other public 0.02%

    Turnout: all 93.12% · promoters 99.94% · institutions 94.14% · other public 2.41%

  5. To ratify the remuneration of Cost Auditor for the financial year ending March 31, 2027.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 93.12% · promoters 99.94% · institutions 94.14% · other public 2.41%

  6. Amendments to VDCL Employee Stock Option Plan, 2018.
    Special
    81.78% for18.22% against

    Against: promoters 0.00% · institutions 41.81% · other public 0.08%

    Turnout: all 93.12% · promoters 99.94% · institutions 94.14% · other public 2.41%

  7. Notification and approval of VDCL Employee Stock Option 2018 – Scheme 7 ("the Scheme - 7") and grant of options under the Scheme to the Eligible Employees/Grantees of the Company under the Scheme.
    Special
    81.78% for18.22% against

    Against: promoters 0.00% · institutions 41.81% · other public 0.08%

    Turnout: all 93.12% · promoters 99.94% · institutions 94.14% · other public 2.41%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 20 Aug 2026, 2 resolutions

69,984 shareholders on the register on 17 Jul 2026; votes counted by Balaramakrishna Desina / Balaramakrishna and Associates.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Satyanarayana Murthy Chavali (DIN: 00142138) as an Independent Director of the Company.
    Special
    99.15% for0.85% against

    Against: promoters 0.00% · institutions 1.96% · other public 3.10%

    Turnout: all 92.87% · promoters 99.94% · institutions 93.95% · other public 0.31%

  2. Appointment of Mr. Dipinder Singh Sekhon (DIN: 01000924) as an Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.18%

    Turnout: all 92.87% · promoters 99.94% · institutions 93.95% · other public 0.31%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 May 2026, 2 resolutions

63,545 shareholders on the register on 3 Apr 2026; votes counted by Balaramakrishna Desina / Balaramakrishna and Associates.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Ravi Shankararamiah, (DIN: 00180746) as an independent director of the company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.25%

    Turnout: all 93.52% · promoters 99.94% · institutions 94.71% · other public 0.34%

  2. Appointment of Dr. Sasikala Paruchuri Kola, (DIN: 00129614) as an independent director of the company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.03%

    Turnout: all 93.52% · promoters 99.94% · institutions 94.71% · other public 0.34%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 5 Sep 2025, 6 resolutions

60,773 shareholders on the register on 29 Aug 2025; present: 9 promoters and 82 others; votes counted by Balaramakrishna Desina / Balaramakrishna and Associates.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2025, and the Reports of the Board of Directors and Statutory Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 93.91% · promoters 100.00% · institutions 94.84% · other public 3.71%

  2. To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, and the Report of Statutory Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 93.91% · promoters 100.00% · institutions 94.84% · other public 3.71%

  3. To declare final dividend of Rs.2/- (i.e., 200%) per equity share of face value of Rs.1/- each for the financial year ended March 31, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 93.91% · promoters 100.00% · institutions 94.84% · other public 3.71%

  4. To appoint a director in place of Mr. Sunil Chandra Kondapally (DIN: 01409332), who retires by rotation in terms of section 152(6) of the Companies Act, 2013, and being eligible, offers himself for reappointment.MoreLess
    OrdinaryPromoters have an interest in it
    74.08% for25.92% against

    Against: promoters 0.00% · institutions 54.36% · other public 0.12%

    Turnout: all 86.34% · promoters 85.61% · institutions 94.84% · other public 3.71%

  5. To ratify the remuneration of Cost Auditor for the financial year ending March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.17%

    Turnout: all 93.91% · promoters 100.00% · institutions 94.84% · other public 3.71%

  6. To Appoint M/s. Balaramakrishna & Associates, Practicing Companies Secretaries as Secretarial Auditors of the Company for the period of 5 years from FY 2025-26 to FY 2029–30.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 93.91% · promoters 100.00% · institutions 94.84% · other public 3.71%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Meeting called by the tribunal, 25 Apr 2025, 1 resolution

65,418 shareholders on the register on 18 Apr 2025; present: 5 promoters and 51 others; votes counted by CS M V Padmaja Kalyani / CS M V Padmaja Kalyani.The company's voting result (opens in a new tab)

  1. Approval of the Scheme of Amalgamation between Medinova Diagnostic Services Limited (Transferor Company) and Vijaya Diagnostic Centre Limited (Transferee Company) and their respective Shareholders and Creditors (Scheme) under Sections 230 to 232 of the Companies Act, 2013 and the rules framed thereunderMoreLess
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 94.19% · promoters 99.92% · institutions 95.35% · other public 1.85%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 6 Sep 2024, 7 resolutions

Present: 11 promoters and 62 others.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Standalone FinancialnStatements of the Company for the financial year endednMarch 31, 2024, and the Reports of the Board of Directorsnand Statutory Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 93.27% · promoters 100.00% · institutions 94.58% · other public 1.47%

  2. To consider and adopt the Audited ConsolidatednFinancial Statements of the Company for the financialnyear ended March 31, 2024, and the Report of StatutorynAuditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 93.27% · promoters 100.00% · institutions 94.58% · other public 1.47%

  3. To declare final dividend of ¿1 (i.e., 100%) per equity sharenof face value of ¿1/- each for the financial year endednMarch 31, 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 93.27% · promoters 100.00% · institutions 94.60% · other public 1.47%

  4. To appoint a director in place of Dr. Sura SurendranathnReddy (DIN: 00108599), who retires by rotation in termsnof Section 152(6) of the Companies Act, 2013, and beingneligible, offers himself for re-appointmentMoreLess
    OrdinaryPromoters have an interest in it
    97.39% for2.61% against

    Against: promoters 0.00% · institutions 2.62% · other public 0.19%

    Turnout: all 39.40% · promoters 0.07% · institutions 94.60% · other public 1.47%

  5. To ratify the remuneration of Cost Auditor for thenfinancial year ending March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.23%

    Turnout: all 93.27% · promoters 100.00% · institutions 94.60% · other public 1.47%

  6. To consider and approve the re-appointment ofnDr. Sura Surendranath Reddy (DIN: 00108599) as anWhole-Time Director and Chairman of the Companynfor a term of five (5) years
    SpecialPromoters have an interest in it
    97.46% for2.54% against

    Against: promoters 0.00% · institutions 2.55% · other public 0.23%

    Turnout: all 39.40% · promoters 0.07% · institutions 94.60% · other public 1.47%

  7. To consider and approve the re-appointment ofnMr. Sunil Chandra Kondapally (DIN: 01409332) as anWhole-Time Director of the Company for a term ofnfive (5) years
    SpecialPromoters have an interest in it
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.03% · other public 0.23%

    Turnout: all 39.40% · promoters 0.07% · institutions 94.60% · other public 1.47%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 20 Sep 2023, 9 resolutions

Present: 15 promoters and 73 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023 and the Reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  2. To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023 and the Report of Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  3. To declare Final Dividend of Re.1/- (100%) per equity share of face value of Re.1/- each for the financial year ended March 31, 2023
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  4. To appoint a Director in the place of Mrs. Sura Geeta Reddy (DIN: 01073233), who retires by rotation and being eligible offers herself for re-appointment
    Ordinary
    96.18% for3.82% against

    Against: promoters 0.00% · institutions 9.98% · other public 0.27%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  5. To re-appoint M/s. B S R and Co, Chartered Accountants as statutory auditors of the Company and to fix their remuneration
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.26%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  6. To consider and ratify the remuneration of Cost auditor for the financial year 2023-24
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.28%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  7. To consider and revise the borrowing limit under Section 180(1)(c) of the Companies Act, 2013
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.27%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  8. To consider and revise the limit under Section 180(1)(a) of the Companies Act, 2013, for creation of charge on the assets of the Company, both present and future, in respect of its borrowings
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.27%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

  9. To consider and approve the appointment of Ms. Sura Suprita Reddy (DIN: 00263618) as, Managing Director and Chief Executive Officer (MD & CEO) of the Company, not liable to retire by rotation and approve the remuneration payable to herMoreLess
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.04% · other public 0.27%

    Turnout: all 90.35% · promoters 100.00% · institutions 87.74% · other public 15.57%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Sep 2022, 6 resolutions

Present: 5 promoters and 50 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: a. The Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2022 together with reports of the Board of Directors and the Auditors thereon. b.The Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022 along with schedules or notes made there under and report of the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 89.48% · promoters 99.94% · institutions 86.71% · other public 5.59%

  2. To declare Final Dividend of Re. 1/- (100%) per equity share of face value of Re. 1/- each for the financial year ended March 31, 2022
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 89.48% · promoters 99.94% · institutions 86.71% · other public 5.59%

  3. To appoint a Director in place of Mr. Sunil Kondapally Chandra (DIN: 01409332), who retires by rotation and being eligible offers himself for re-appointment.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.17%

    Turnout: all 89.48% · promoters 99.94% · institutions 86.71% · other public 5.59%

  4. Ratification of remuneration payable to Cost Auditor who was appointed in casual vacancy, for the Financial Year 2021-22.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 89.48% · promoters 99.94% · institutions 86.71% · other public 5.59%

  5. Ratification of remuneration payable to Cost Auditor for the Financial Year 2022-23.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 89.48% · promoters 99.94% · institutions 86.71% · other public 5.59%

  6. Extension of loan to Medinova Diagnostic Services Limited, Subsidiary Company
    Special
    96.72% for3.28% against

    Against: promoters 0.00% · institutions 8.50% · other public 0.26%

    Turnout: all 89.48% · promoters 99.94% · institutions 86.71% · other public 5.59%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 24 Sep 2026, 10 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, and the Reports of the Board of Directors and Statutory Auditors thereon.
    10 for0 against
  • To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the Report of Statutory Auditors thereon
    10 for0 against
  • To declare final dividend of ₹2 (i.e., 200%) per equity share of face value of ₹1/- each for the financial year ended March 31, 2026
    10 for0 against
  • To appoint a director in place of Mrs. Sura Geeta Reddy (DIN: 01073233), who retires by rotation in terms of section 152(6) of the Companies Act, 2013, and being eligible, offers herself for re-appointment.MoreLess
    Against HSBC Mutual Fund
    • HSBC Mutual FundA vote AGAINST the following nominees is warranted because: • Sura Geeta Reddy has failed to attend at least 75 percent of board and committee meetings in the most recent fiscal year, without a satisfactory explanation.
    9 for1 against
  • To ratify the remuneration of Cost Auditor for the financial year ending March 31, 2027.
    10 for0 against
  • Amendments to VDCL Employee Stock Option Plan, 2018.
    Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, HSBC Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundCompliance, Governance and Transparency Concerns identified on the underlying pool / schemes. Interconnected with Resolution #7.
    • DSP Mutual Fund, Jio BlackRock Mutual FundThe company seeks approval to increase the pool size to reward employees for its sustained growth. The company has stated that its diagnostic network has expanded from 81 centres to 162 centres, which has resulted in a substantial increase in the company's employee base. Only 162,414 stock options remain in the present pool size. With the proposed increase in pool size and residual stock options left in the existing pool, the overall dilution shall be ~2.1% of the expanded capital base as on 30 June 2026. The maximum exercise period shall be ten years, which we believe to be excessive. Further, the exercise price for the expanded pool size shall be at a discount of up to 30% on the average closing price of the company’s shares during the three months preceding the month of the grant date. We do not favour ESOP schemes where the exercise price can be at a significant discount (greater than 20%) to market price. ESOPs are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the options are issued at significant discount to the market price. The vesting appears to be time based with criteria such as company joining date, grade of the employee, performance, period of service with the company or subsidiary, criticality or any other criteria. In case of a deep discount we expect the vesting of the stock options to be based on clearly defined performance metrics along with a confirmation that the targets along with their achievement will be disclosed by the company in the subsequent annual reports. Given the lack of clarity on the exercise price and the long exercise period, we do not support the scheme. Hence, we do not support the resolution.
    • Edelweiss Mutual Fund, Navi Mutual FundProposed Amendment is Compliant with law. However, Compliance, Governance and Transparency Concerns identified on the underlying pool / schemes. Interconnected with Resolution #7.
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The scheme permits stock options to be issued with an exercise price at a discount to the market price on grant date.
    4 for6 against
  • Notification and approval of VDCL Employee Stock Option 2018 – Scheme 7 ("the Scheme - 7") and grant of options under the Scheme to the Eligible Employees/Grantees of the Company under the Scheme.
    Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, HSBC Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundExercise period is inadequately disclosed, the Nomination and Remuneration Committee having power to alter vary Exercise Period under the proposed Scheme 7. Governance and Transparency Concern: Potential maximum economic benefits to a single employee appears to be disproportionate/excessive considering the size of operation and performance of the Company.
    • DSP Mutual Fund, Jio BlackRock Mutual FundThrough resolution #7, the company proposes to use the amended scheme to introduce a sub-scheme of VDCL Employee Stock Option Plan 2018 – Scheme 7. Our views on this resolution are linked to our views on Resolution #6. We do not support the resolution.
    • Edelweiss Mutual Fund, Navi Mutual FundNon-compliance with SEBI (SBEB & SE) Regulations, 2021: Exercise period is inadequately disclosed, the NRC having power to alter vary Exercise Period under the proposed Scheme 7. Governance and Transparency Concern: Potential maximum economic benefits to a single employee appears to be disproportionate/excessive considering the size of operation and performance of the Company.
    • HSBC Mutual FundA vote AGAINST the resolution is warranted because: • The scheme permits stock options to be issued with an exercise price at a discount to the market price on grant date.
    4 for6 against

Mutual fund votes, meeting of 20 Aug 2026, 10 fund houses so far (houses' deadline to file 15 Oct 2026)

  • Appointment of Mr. Satyanarayana Murthy Chavali (DIN: 00142138) as an Independent Director of the Company.
    10 for0 against
  • Appointment of Mr. Dipinder Singh Sekhon (DIN: 01000924) as an Independent Director of the Company.
    10 for0 against
6 earlier meetings

Mutual fund votes, meeting of 9 May 2026, 22 fund houses

  • Appointment of Mr. Ravi Shankararamiah, (DIN: 00180746) as an independent director of the company
    22 for0 against
  • Appointment of Dr. Sasikala Paruchuri Kola, (DIN: 00129614) as an independent director of the company.
    22 for0 against

Mutual fund votes, meeting of 5 Sep 2025, 22 fund houses

  • To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2025, and the Reports of the Board of Directors and Statutory Auditors thereon.
    22 for0 against
  • To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, and the Report of Statutory Auditors thereon.
    22 for0 against
  • To declare final dividend of Rs.2/- (i.e., 200%) per equity share of face value of Rs.1/- each for the financial year ended March 31, 2025.
    22 for0 against
  • To appoint a director in place of Mr. Sunil Chandra Kondapally (DIN: 01409332), who retires by rotation in terms of section 152(6) of the Companies Act, 2013, and being eligible, offers himself for reappointment.MoreLess
    Against Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Jio BlackRock Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, SBI Mutual Fund
    • Angel One Mutual Fund, Nippon India Mutual FundGovernance concern: Low attendance at board meetings.
    • Axis Mutual Fund, Bank of India Mutual Fund, Jio BlackRock Mutual Fund, SBI Mutual FundSunil Chandra Kondapally, 50, is part of the promoter family and serves as Whole-time Director. He has been associated with Vijaya Diagnostic Centre Limited since inception. He also serves as Managing Director of Medinova Diagnostic Services Ltd. (a listed subsidiary), which is being merged into Vijaya Diagnostic Centre Limited. He also founded pharmaceutical companies Trikona Pharmaceuticals Private Limited in 2016 and QPS Bioserve India Private Limited in 2004. While his reappointment is in line with statutory requirements, we raise concern over his low board meeting attendance. He attended three out of five (60%) board meetings held in FY25 and ten out of fifteen (67%) board meetings held in the past three years. We expect directors to attend all board meetings and have a threshold of 75% attendance over a three-year period. Given his low attendance, we do not support the resolution.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. Governance concern: Low attendance at board meetings.
    11 for11 against
  • To ratify the remuneration of Cost Auditor for the financial year ending March 31, 2026.
    22 for0 against
  • To Appoint M/s. Balaramakrishna & Associates, Practicing Companies Secretaries as Secretarial Auditors of the Company for the period of 5 years from FY 2025-26 to FY 2029–30.
    22 for0 against

Mutual fund votes, meeting of 25 Apr 2025, 22 fund houses

  • Approval of the Scheme of Amalgamation between Medinova Diagnostic Services Limited (Transferor Company) and Vijaya Diagnostic Centre Limited (Transferee Company) and their respective Shareholders and Creditors (Scheme) under Sections 230 to 232 of the Companies Act, 2013 and the rules framed thereunderMoreLess
    22 for0 against

Mutual fund votes, meeting of 6 Sep 2024, 16 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To consider and adopt the Audited Standalone FinancialnStatements of the Company for the financial year endednMarch 31, 2024, and the Reports of the Board of Directorsnand Statutory Auditors thereon
    15 for0 against
  • To consider and adopt the Audited ConsolidatednFinancial Statements of the Company for the financialnyear ended March 31, 2024, and the Report of StatutorynAuditors thereon
    16 for0 against
  • To declare final dividend of ¿1 (i.e., 100%) per equity sharenof face value of ¿1/- each for the financial year endednMarch 31, 2024.
    16 for0 against
  • To appoint a director in place of Dr. Sura SurendranathnReddy (DIN: 00108599), who retires by rotation in termsnof Section 152(6) of the Companies Act, 2013, and beingneligible, offers himself for re-appointmentMoreLess
    Against Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with Law. No issues on merit, experience, eligibility & performance. Governance Concern: Holding combined position of Chairman & ED may lead concentration of power in the hand of a single person.
    12 for3 against
  • To ratify the remuneration of Cost Auditor for thenfinancial year ending March 31, 2025
    15 for0 against
  • To consider and approve the re-appointment ofnDr. Sura Surendranath Reddy (DIN: 00108599) as anWhole-Time Director and Chairman of the Companynfor a term of five (5) years
    Against Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with Law. No issues on merit, experience, eligibility & performance. Governance Concern: Holding combined position of Chairman & ED may lead concentration of power in the hand of a single person.
    13 for3 against
  • To consider and approve the re-appointment ofnMr. Sunil Chandra Kondapally (DIN: 01409332) as anWhole-Time Director of the Company for a term ofnfive (5) years
    16 for0 against
3 proposals not matched to one resolution
  • Adoption of consolidated financial statements for the year ended 31 March 2024
    1 for0 against
  • Ratify remuneration of Rs. 30,000 payable to TSSV Santhosh Kumar as cost auditor for FY25
    1 for0 against
  • Reappoint Dr. Sura Surendranath Reddy (DIN: 00108599) as Director, liable to retire by rotation
    1 for0 against

Mutual fund votes, meeting of 20 Sep 2023, 9 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023 and the Reports of the Board of Directors and Auditors thereon
    9 for0 against
  • To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023 and the Report of Auditors thereon
    9 for0 against
  • To declare Final Dividend of Re.1/- (100%) per equity share of face value of Re.1/- each for the financial year ended March 31, 2023
    9 for0 against
  • To appoint a Director in the place of Mrs. Sura Geeta Reddy (DIN: 01073233), who retires by rotation and being eligible offers herself for re-appointment
    9 for0 against
  • To re-appoint M/s. B S R and Co, Chartered Accountants as statutory auditors of the Company and to fix their remuneration
    9 for0 against
  • To consider and ratify the remuneration of Cost auditor for the financial year 2023-24
    9 for0 against
  • To consider and revise the borrowing limit under Section 180(1)(c) of the Companies Act, 2013
    8 for0 against
  • To consider and revise the limit under Section 180(1)(a) of the Companies Act, 2013, for creation of charge on the assets of the Company, both present and future, in respect of its borrowings
    8 for0 against
  • To consider and approve the appointment of Ms. Sura Suprita Reddy (DIN: 00263618) as, Managing Director and Chief Executive Officer (MD & CEO) of the Company, not liable to retire by rotation and approve the remuneration payable to herMoreLess
    9 for0 against
2 proposals not matched to one resolution
  • Approve creation of charge/ mortgage/hypothecation/ pledge on the assets of the company upto the borrowing limits
    1 for0 against
  • Approve revision in borrowing limit to aggregate of paid-up share capital, securities premium and free reserves
    1 for0 against

Mutual fund votes, meeting of 28 Sep 2022, 9 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt: a. The Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2022 together with reports of the Board of Directors and the Auditors thereon. b.The Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022 along with schedules or notes made there under and report of the Auditors thereon.MoreLess
    8 for0 against
  • To declare Final Dividend of Re. 1/- (100%) per equity share of face value of Re. 1/- each for the financial year ended March 31, 2022
    9 for0 against
  • To appoint a Director in place of Mr. Sunil Kondapally Chandra (DIN: 01409332), who retires by rotation and being eligible offers himself for re-appointment.
    9 for0 against
  • Ratification of remuneration payable to Cost Auditor who was appointed in casual vacancy, for the Financial Year 2021-22.
    8 for0 against
  • Ratification of remuneration payable to Cost Auditor for the Financial Year 2022-23.
    8 for0 against
  • Extension of loan to Medinova Diagnostic Services Limited, Subsidiary Company
    Against Franklin Templeton Mutual Fund, HSBC Mutual Fund
    • Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • There is no clarity if the proposed arrangement will be completed in the company's ordinary course of business and conducted at arm's length. • The terms of the request do not provide for further shareholder review and vote on the arrangement on a periodic basis. • The company has not provided sufficient information, which prevents shareholders from making an informed voting decision.
    • HSBC Mutual FundA vote AGAINST this resolution is desired due to negative impact on shareholder value.There is no clarity if the proposed arrangement will be completed in the company's ordinary course of business and conducted at arm's length. -The terms of the request do not provide for further shareholder review and vote on the arrangement on a periodic basis. -The company has not provided sufficient information, which prevents shareholders from making an informed voting decision.
    7 for2 against
4 proposals not matched to one resolution
  • Accept Consolidated Financial Statements and Statutory Reports
    1 for0 against
  • Accept Standalone Financial Statements and Statutory Reports
    1 for0 against
  • Ratify remuneration of Rs. 30,000 payable to TSSV Santhosh Kumar as cost auditor for FY22, filling the casual vacancy caused by the demise of existing cost auditor N.V.S. Kapardhi
    1 for0 against
  • Ratify remuneration of Rs. 30,000 payable to TSSV Santhosh Kumar as cost auditor for FY23
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 2 complaints open, quarter to Mar 2026.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.